...are immeasurable. The many companies he formed (Alza, Affymax, Alexza, Affymetrix, Dynapol, DNAX, Symyx, Maxygen, SurroMed...

...PPDI will acquire SurroMed's biomarker business. In exchange, PPDI will cancel the SurroMed preferred shares it...
...shares it received in 2002 and 2003. In addition, PPDI will assume $3.4 million of SurroMed's...
...PPDI also will guarantee repayment of up to $1.5 million of a SurroMed bank loan. SurroMed...

...discover pain-related proteomic biomarkers 8/18/03 Wyeth Study biomarkers to compare Wyeth compounds for inflammation 7/21/03 SurroMed...

...to create an independent service-based biomarker company," agreed Gordon Ringold, co-founder, chairman and CEO of SurroMed Inc....
...of has agreed to give royalties on a product in a deal for biomarkers." Although SurroMed...
...short term, the company is transitioning toward developing diagnostics for its own account. In 2002, SurroMed...

...Bala Manian, chairman and co-founder of Reametrix Inc., and co-founder of Quantum Dot Corp. and Surromed...

...Under an expansion of an existing deal, SurroMed will do proteomic analysis using its biomarker discovery...
...preclinical samples provided by MRK to identify potential biological markers. Financial terms were not disclosed. SurroMed Inc....

...identify novel biomarkers of progression to overt Type II diabetes. The study was conducted for SurroMed Inc....

...The companies extended their 2002 deal, under which SurroMed is characterizing the responses of multiple sclerosis...
...BIIB's Avonex interferon beta-1a (see BioCentury, June 24, 2002). Biogen Idec Inc. (BIIB), Cambridge, Mass. SurroMed Inc....

...therapeutically relevant protein networks derived from experimental results. Ingenuity Systems Inc. , Mountain View, Calif. SurroMed Inc....